checkAd

Tauriga Sciences Inc. Generates Record Weekly Net E-Commerce Sales


For the Following Weekly Period: November 22nd-28th, 2021 or Thanksgiving Week 2021

NEW YORK, NY, Nov. 29, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- Tauriga Sciences, Inc. (OTCQB: TAUG) (“Tauriga” or the “Company”), a New York based diversified Life Sciences Company, today announced that it has generated record weekly net E-Commerce revenue (“sales”), for the following period: Monday November 22, 2021 through Sunday November 28, 2021. The Company’s net E-Commerce sales, for this one-week period, have exceeded $22,000 for the first time.  The Company is confident about its business prospects for the remainder of Calendar Year 2021 and beyond. 

Throughout its current operating Quarter (3rd Fiscal Quarter 2022), the Company has experienced an acceleration in revenue growth – concerning its highest margin E-Commerce business segment.  Driving this revenue growth are several important factors: innovative product offerings, increased orders from repeat customers, and aggressive new marketing strategies. 

The Company is firmly on track to generate record quarterly revenue (net revenue), for its 3rd Fiscal Quarter 2022.  The Company expects that net revenue generated for this quarter, when completed, will be substantially greater than any other previous quarter.  

Please visit the Company’s recently upgraded E-Commerce website, at:   https://taurigum.com

Lastly, the Company wishes to congratulate Aegea Biotechnololgies, Inc. (“Aegea”) on the completed clinical validation for its new COVID-19 Assay (“Test”).  Tauriga Sciences, Inc. currently holds a meaningful equity stake in Aegea.  

** Please Note: 3rd Fiscal Quarter 2022 (Period: October 1, 2021 – December 31, 2021)

ABOUT TAURIGA SCIENCES INC.

Tauriga Sciences, Inc. (TAUG) is a revenue generating, diversified life sciences company, engaged in several major business activities and initiatives.  The company manufactures and distributes several proprietary retail products and product lines, mainly focused on the Cannabidiol (“CBD”) and Cannabigerol (“CBG”) Edibles market segment.  The main product line, branded as Tauri-Gum, consists of a proprietary supplement chewing gum that is Kosher certified, Halal certified, and Vegan Formulated (CBD Infused Tauri-Gum Flavors: Mint, Blood Orange, Pomegranate), (CBG Infused Tauri-Gum Flavors: Peach-Lemon, Black Currant), (DELTA 8 THC Infused Tauri-Gum Flavor: Evergreen Mint), (Vitamin C + Zinc Infused Tauri-Gum Flavor: Pear Bellini), (Caffeine Infused Tauri-Gum Flavor: Cherry Lime Rickey), & (Vitamin D3 Infused Tauri-Gum Flavor: Golden Raspberry).  The Company’s commercialization strategy consists of a broad array of retail customers, distributors, and a fast-growing E-Commerce business segment (E-Commerce website: www.taurigum.com). Please visit our corporate website, for additional information, as well as inquiries, at http://www.tauriga.com

Seite 1 von 3


Wertpapier



0 Kommentare
Nachrichtenquelle: globenewswire
29.11.2021, 16:06  |  137   |   |   

Schreibe Deinen Kommentar

Bitte melden Sie sich an, um zu kommentieren. Anmelden | Registrieren

 

Disclaimer

Tauriga Sciences Inc. Generates Record Weekly Net E-Commerce Sales For the Following Weekly Period: November 22nd-28th, 2021 or Thanksgiving Week 2021 NEW YORK, NY, Nov. 29, 2021 (GLOBE NEWSWIRE) - via NewMediaWire - Tauriga Sciences, Inc. (OTCQB: TAUG) (“Tauriga” or the “Company”), a New York based …

Nachrichten des Autors

Titel
Titel
Titel
Titel